CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 28 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,979 | -66.5% | 28,759 | -43.7% | 0.00% | – |
| Q2 2023 | $29,797 | +43719.1% | 51,110 | -57.1% | 0.00% | – |
| Q1 2023 | $68 | -51.1% | 119,158 | -42.7% | 0.00% | – |
| Q4 2022 | $139 | -100.0% | 208,062 | +6.5% | 0.00% | – |
| Q3 2022 | $285,000 | +152.2% | 195,445 | +87.1% | 0.00% | – |
| Q2 2022 | $113,000 | +189.7% | 104,443 | +934.8% | 0.00% | – |
| Q4 2021 | $39,000 | -83.0% | 10,093 | -79.5% | 0.00% | – |
| Q2 2020 | $229,000 | – | 49,201 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 388,632 | $2,048,000 | 1.16% |
| Tri Locum Partners LP | 522,943 | $2,756,000 | 1.10% |
| Sio Capital Management, LLC | 422,598 | $2,227,000 | 0.71% |
| Affinity Asset Advisors, LLC | 400,000 | $2,108,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 508,322 | $2,679,000 | 0.22% |
| Ikarian Capital, LLC | 99,422 | $524,000 | 0.04% |
| PURA VIDA INVESTMENTS, LLC | 105,141 | $554,000 | 0.02% |
| Virtu Financial LLC | 20,029 | $106,000 | 0.01% |
| NEXT Financial Group, Inc | 14,752 | $77,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 103,925 | $548,000 | 0.01% |